Cas:566905-88-2 benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate manufacturer & supplier

We serve Chemical Name:benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate CAS:566905-88-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate

Chemical Name:benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate
CAS.NO:566905-88-2
Synonyms:benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate
Molecular Formula:C17H25NO3
Molecular Weight:291.38500
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.77000
Exact Mass:291.18300
LogP:3.13570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate Use and application,benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate technical grade,usp/ep/jp grade.


Related News: What’s the background? benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate manufacturer The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate supplier The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate vendor Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. benzyl 4-(4-hydroxybutyl)piperidine-1-carboxylate factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.